These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

668 related items for PubMed ID: 19667709

  • 1. Microalbuminuria, insulin resistance, diabetes, hypertension, and kidney function: the latest concepts in pathology and pharmacologic treatment.
    Barri YM, Palmer BF, Ram CV.
    Postgrad Med; 2005 Dec; 118(6 Suppl Beta-Blockers):34-45. PubMed ID: 19667709
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Angiotensin converting enzyme inhibitors in diabetic patients with microalbuminuria or normoalbuminuria.
    Viberti G, Chaturvedi N.
    Kidney Int Suppl; 1997 Dec; 63():S32-5. PubMed ID: 9407417
    [Abstract] [Full Text] [Related]

  • 4. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
    de Zeeuw D.
    Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
    [Abstract] [Full Text] [Related]

  • 5. [Microalbuminuria in essential hypertension: of limited value as an indicator of patients with a high risk for complications].
    Stehouwer CD, Jager A, Donker AJ.
    Ned Tijdschr Geneeskd; 1997 Aug 23; 141(34):1649-53. PubMed ID: 9543776
    [Abstract] [Full Text] [Related]

  • 6. Microalbuminuria: a common, independent cardiovascular risk factor, especially but not exclusively in type 2 diabetes.
    Donnelly R, Yeung JM, Manning G.
    J Hypertens Suppl; 2003 Mar 23; 21(1):S7-12. PubMed ID: 12769161
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Microalbuminuria as a target to improve cardiovascular and renal outcomes.
    Basi S, Lewis JB.
    Am J Kidney Dis; 2006 Jun 23; 47(6):927-46. PubMed ID: 16731288
    [Abstract] [Full Text] [Related]

  • 10. Therapeutic effects of angiotensin II inhibition or blockade on the progression of chronic renal disease.
    Cantarovich F, Rangoonwala B.
    Int J Clin Pract; 2003 Nov 23; 57(9):801-22. PubMed ID: 14686572
    [Abstract] [Full Text] [Related]

  • 11. [Hypertension, microalbuminuria and insulin resistance in diabetes mellitus].
    Bretzel RG.
    Wien Klin Wochenschr; 1994 Nov 23; 106(24):774-92. PubMed ID: 7846897
    [Abstract] [Full Text] [Related]

  • 12. Hypertension and the renal vascular complications of diabetes: a structural basis to guide management.
    Viberti GC.
    Schweiz Med Wochenschr; 1994 Nov 05; 124(44):1938-40. PubMed ID: 7973521
    [Abstract] [Full Text] [Related]

  • 13. Twelve shifting paradigms in diabetic renal disease and hypertension.
    Mogensen CE.
    Diabetes Res Clin Pract; 2008 Nov 13; 82 Suppl 1():S2-9. PubMed ID: 18947897
    [Abstract] [Full Text] [Related]

  • 14. Determinants of progression from microalbuminuria to proteinuria in patients who have type 1 diabetes and are treated with angiotensin-converting enzyme inhibitors.
    Ficociello LH, Perkins BA, Silva KH, Finkelstein DM, Ignatowska-Switalska H, Gaciong Z, Cupples LA, Aschengrau A, Warram JH, Krolewski AS.
    Clin J Am Soc Nephrol; 2007 May 13; 2(3):461-9. PubMed ID: 17699452
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. ACE inhibitor intervention in Type 1 diabetes with low grade microalbuminuria.
    Poulsen PL.
    J Renin Angiotensin Aldosterone Syst; 2003 Mar 13; 4(1):17-26. PubMed ID: 12692749
    [Abstract] [Full Text] [Related]

  • 17. Microalbuminuria in non-insulin dependent diabetes and essential hypertension--a marker of severe disease.
    Ahmed S.
    J Assoc Physicians India; 1995 Jul 13; 43(7):517-8. PubMed ID: 8713236
    [No Abstract] [Full Text] [Related]

  • 18. [Role of the renin-angiotensin system in the pathogenesis, clinical picture and treatment of diabetic nephropathy].
    Wittmann I, Degrell P, Komáromy A, Molnár GA, Wagner Z, Wagner L, Mazák I, Nagy J.
    Orv Hetil; 2003 Mar 30; 144(13):613-9. PubMed ID: 12728786
    [Abstract] [Full Text] [Related]

  • 19. The reno-protective role of AT(1)-receptor blockers.
    Mogensen CE.
    J Hum Hypertens; 2002 Aug 30; 16 Suppl 3():S52-8. PubMed ID: 12140729
    [Abstract] [Full Text] [Related]

  • 20. Use of losartan in reducing microalbuminuria in normotensive patients with type-2 diabetes mellitus.
    Agha A, Bashir K, Anwar E.
    Nepal Med Coll J; 2007 Jun 30; 9(2):79-83. PubMed ID: 17899953
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.